We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLNE icon
1526
Hamilton Lane
HLNE
$5.53B
$274K 0.01%
+4,060
New +$256K
SFL icon
1527
SFL Corp
SFL
$1.58B
$274K 0.01%
29,502
+24,819
+530% +$248K
SUM
1528
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$274K 0.01%
+17,289
New +$248K
PACW
1529
DELISTED
PacWest Bancorp
PACW
$274K 0.01%
13,882
+13,763
+11,566% +$255K
QUOT
1530
DELISTED
Quotient Technology Inc
QUOT
$274K 0.01%
+37,411
New +$250K
ETFC
1531
DELISTED
E*Trade Financial Corporation
ETFC
$274K 0.01%
5,500
-9,228
-63% -$398K
AWK icon
1532
American Water Works
AWK
$26.9B
$273K 0.01%
2,125
-402
-16% -$50.1K
EWT icon
1533
iShares MSCI Taiwan ETF
EWT
$11B
$273K 0.01%
6,786
+1,590
+31% +$59.2K
EWY icon
1534
iShares MSCI South Korea ETF
EWY
$25.2B
$273K 0.01%
4,779
+2,106
+79% +$111K
INSP icon
1535
Inspire Medical Systems
INSP
$1.73B
$272K 0.01%
+3,131
New +$241K
MMSI icon
1536
Merit Medical Systems
MMSI
$5.36B
$272K 0.01%
+5,964
New +$241K
ROM icon
1537
ProShares Ultra Technology
ROM
$1.27B
$272K 0.01%
11,664
-59,632
-84% -$1.14M
MRTX
1538
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$272K 0.01%
2,383
+2,358
+9,432% +$229K
CDP icon
1539
COPT Defense Properties
CDP
$4.14B
$271K 0.01%
+10,703
New +$267K
AMX icon
1540
America Movil
AMX
$71.7B
$270K 0.01%
21,267
-48,602
-70% -$607K
BWXT icon
1541
BWX Technologies
BWXT
$15.5B
$270K 0.01%
4,767
+1,611
+51% +$90.1K
OMC icon
1542
Omnicom Group
OMC
$23.2B
$270K 0.01%
4,944
-1,740
-26% -$94.7K
NVTA
1543
DELISTED
Invitae Corporation
NVTA
$270K 0.01%
+8,914
New +$156K
AVYA
1544
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$270K 0.01%
21,788
+7,517
+53% +$86.6K
CBFV icon
1545
CB Financial Services
CBFV
$190M
$269K 0.01%
+12,329
New +$275K
AIMT
1546
DELISTED
Aimmune Therapeutics
AIMT
$269K 0.01%
+16,078
New +$273K
CROX icon
1547
Crocs
CROX
$6.63B
$268K 0.01%
+7,283
New +$193K
CSW
1548
CSW Industrials
CSW
$5.67B
$267K 0.01%
+3,862
New +$261K
NTAP icon
1549
NetApp
NTAP
$39B
$267K 0.01%
6,012
-1,288
-18% -$55.3K
CCF
1550
DELISTED
Chase Corporation
CCF
$267K 0.01%
2,605
+2,185
+520% +$204K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.